Argonne scientists led four other laboratories in developing definitive guidance on how to value pumped storage hydropower projects. Their efforts resulted in DOE publication of the Pumped Storage Hydropower Valuation Guidebook: A Cost-Benefit and Decision Analysis Valuation Framework. The guide provides an objective, transparent valuation methodology and helps measure both monetary and non-monetary value streams.
As COVID-19 vaccines slowly roll out across the world, government officials in densely populated countries must still manage vulnerable communities at highest risk of an outbreak. In a new study published in the journal Risk Analysis, researchers in India propose a COVID Risk Assessment and Mapping (CRAM) framework that results in a zoned map that officials can use to place more targeted restrictions on high-risk communities. Successfully used by officials in Jaipur at the peak of the pandemic last spring, their framework could help other vulnerable countries avoid a shutdown of their regional economies.
Hydrogen technology has the potential to transform aspects of the energy landscape, according to a new report from Argonne scientists.
The University of Arkansas at Little Rock has received a $300,000 grant from the U.S. Department of Commerce’s Economic Development Administration. The two-year project will include the creation of an economic recovery plan as well as the development of a history of the economic impact of COVID-19 on the state.
Argonne’s ReCell Center has already made pivotal discoveries as scientists create and test new recycling processes and battery designs. These discoveries will help grow a globally competitive U.S. recycling industry.
Oliver Williamson, a UC Berkeley and Haas School of Business professor for nearly three decades whose elegant framework for analyzing the structure of organizations won him a Nobel Prize in Economic Sciences, passed away on May 21, 2020 in Berkeley, Calif. at the age of 87. His death followed a period of failing health. Williamson’s work permanently changed how economists view organizations.
Is personalized medicine cost-effective? Researchers have answered that question for one medical treatment, genotype-guided antiplatelet therapy for acute coronary syndrome patients with PCI. Their study uses pharmacogenomics and economic analysis of real-world clinical data.
Rutgers scholar and economist Bruce Mizrach is available to comment on stresses on the housing market and…
EXPERT PITCH: Disruption of sports has ‘substantial, uncertain’ impact on long-term broadcast rights, ticket sales, fan attendance, says WVU economist
With fears over the novel coronavirus shuttering the sports world, Brad Humphreys, economics professor at…
Expert analysis by Thunderbird’s Doug Guthrie: The Age of Cooptation: The Cost of Doing Business in Xi’s China
The Age of Cooptation: The Cost of Doing Business in Xi’s China (Business, China, China…